Article D773-20
…t-hand column of the same table:Applicable articlesIn the wording resulting from the decreeD. 532-36n° 2017-1324 of 6 September 2017D. 532-37 with the exception of III and IVNo. 2021-941 of 15 July 20…
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 4101–4110 of 23747 articles for “Art. Cass. com. 13 septembre 2017 n° 16-12479”
…t-hand column of the same table:Applicable articlesIn the wording resulting from the decreeD. 532-36n° 2017-1324 of 6 September 2017D. 532-37 with the exception of III and IVNo. 2021-941 of 15 July 20…
…t-hand column of the same table:Applicable articlesIn the version resulting from the decreeD. 532-36n° 2017-1324 of 6 September 2017D. 532-37 with the exception of III and IVNo. 2021-941 of 15 July 20…
…nd column of the same table:Applicable articlesIn the wording resulting from the decreeD. 532-36No. 2017-1324 of 6 September 2017D. 532-37 with the exception of III and IVNo. 2021-941 of 15 July 2021D…
…be kept in electronic form. A qualified electronic signature meeting the requirements of Decree no. 2017-1416 of 28 September 2017 on electronic signatures shall be used.
Before administering the punctually prepared advanced therapy medicinal product, the health professional in the health establishment must ensure that the information required for the traceability of t…
The regional pharmacovigilance centres inform the Agence nationale de sécurité du médicament et des produits de santé on the same day of the reports of adverse reactions likely to be due to a blood-de…
The pharmacovigilance carried out on individually prepared advanced therapy medicinal products includes monitoring to ensure traceability between the various stages, from the removal of tissues, cells…
Blood establishments and organisations or companies manufacturing or exploiting blood-derived medicinal products which are aware of information likely to cast doubt on the quality of blood or plasma i…
I.-Any establishment or body referred to in Article L. 4211-9-1 or any pharmaceutical establishment referred to in Articles L. 5124-1 or L. 5124-9-1 shall set up and keep up to date a system ensuring…
In the event of interruption or cessation of activity of an establishment or organisation mentioned in article L. 4211-9-1, the data relating to the traceability of advanced therapy medicinal products…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More